Bal at al.(1616. Bal A, Casalegno JS, Melenotte C, Daviet F, Ninove L, Edouard S, et al. Influenza-induced acute respiratory distress syndrome during the 2010-2016 seasons: bacterial co-infections and outcomes by virus type and subtype. Clin Microbiol Infect. 2020;26(7):947.e1-4.) |
2020 |
France |
Retrospective |
H1N1 |
3 |
45 |
- |
56.7±15.6 |
60 |
23.3 (8.0 –32.0) |
Mortality |
6 |
Biswas et al.(1717. Biswas A, Alam F, Hartery K, Brien A, Mahdy S, Hodnett P, et al. H1N1 Pandemic - One Year Follow up Study. Int J Trop Dis Health. 2016;13(2):1-7.) |
2016 |
Ireland |
Case Series |
H1N1 |
12 |
7 |
- |
44.7±13.7 |
- |
- |
Quality of life Functional capacity Pulmonary function Psychiatric disorders |
5 |
Hsieh et al.(1818. Hsieh MJ, Lee WC, Cho HY, Wu MF, Hu HC, Kao KC, et al. Recovery of pulmonary functions, exercise capacity, and quality of life after pulmonary rehabilitation in survivors of ARDS due to severe influenza A (H1N1) pneumonitis. Influenza Other Respir Viruses. 2018;12(5):643-8.) |
2018 |
Taiwan |
Prospective |
H1N1 |
1, 3 and 6 |
9 |
- |
45.11±5.48 |
100 |
16.89±2.51 |
Quality of life Functional capacity Pulmonary function |
6 |
Quispe-Laime et al.(1919. Quispe-Laime AM, Fiore C, González-Ros MN, Bettini JE, Rolfo VE, Campagne CG, et al. [Lung diffusion capacity and quality of life 6 months after discharge from the ICU among survivors of acute respiratory distress syndrome due to influenza A H1N1]. Med Intensiva. 2012;36(1):15-23. Spanish.) |
2012 |
Argentina |
Case Series |
H1N1 |
6 |
11 |
- |
37.27±9.4 |
72.7 |
13.73±7.016 |
Quality of life Pulmonary function |
6 |
Toufen et al.(2020. Toufen C Jr, Costa EL, Hirota AS, Li HY, Amato MB, Carvalho CR. Follow-up after acute respiratory distress syndrome caused by influenza a (H1N1) virus infection. Clinics (São Paulo). 2011;66(6):933-7.) |
2011 |
Brazil |
Case Series |
H1N1 |
2 and 6 |
4 |
- |
37.5±13.5 |
100 |
19.5±5.8 |
Rehospitalization Back to work Pulmonary function |
6 |
Luyt et al.(2121. Luyt CE, Combes A, Richard JC, Mercat A, Brun-Buisson C, Brochard LJ, et al. Long-Term Outcome In Survivors Of Acute Respiratory Distress Syndrome Due To Pandemic 2009 Influenza A (H1N1) Virus Infection. The RESPIFLU Study. Am J Respir Crit Care Med. 2012;2014:A2301.) |
2012 |
France |
Prospective |
H1N1 |
12 |
37 |
ECLA |
35.5 (30– 39) |
42 |
37.5 (19–67) |
Back to work Quality of life Functional capacity Pulmonary function Psychiatric disorders |
8 |
|
|
|
|
|
|
|
Control |
42 (32.75– 51.25) |
52 |
19 (12–27.5) |
|
|
Fariña et al.(2222. Fariña O, Pistillo N; García MA, Dorfman B, Trozzi S, Amundarain Edgard, et al. Evaluacion prospectiva de pacientes com SDRA con sospecha de infeccion por influenza H1N1 en terapia intensiva. Seguimiento a los 30 dias del alta. Rev Hosp El Cruce. 2009;(6):20091230.) |
2009 |
Argentina |
Prospective |
H1N1 |
1 |
5 |
- |
34 (23–54) |
40 |
- |
Mortality |
5 |
Hou et al.(2323. Hou X, Guo L, Zhan Q, Jia X, Mi Y, Li B, et al. Extracorporeal membrane oxygenation for critically ill patients with 2009 influenza A (H1N1)-related acute respiratory distress syndrome: preliminary experience from a single center. Artif Organs. 2012;36(9):780-6.) |
2012 |
China |
Prospective |
H1N1 |
1 and 3 |
9 |
- |
31.2 (21–59) |
31.9 |
31.2 (21–59) |
Mortality |
5 |
Batawi et al.(2424. Batawi S, Tarazan N, Al-Raddadi R, Al Qasim E, Sindi A, Al Johni S, et al. Quality of life reported by survivors after hospitalization for Middle East respiratory syndrome (MERS). Health Qual Life Outcomes. 2019;17(1):101.) |
2019 |
Saudi Arabia |
Transversal |
MERS + SARS |
13.8 |
135 |
MERS |
44.99±12.95 |
71.8 |
- |
Back to work Quality of life |
8 |
|
|
|
|
|
|
|
Non-MERS |
50.04±13.64 |
59.6 |
|
|
|
Guo et al.(2525. Guo L, Han Y, Li J, Chen Q, Ren Y, Wu Q, et al. Long-term outcomes in patients with severe acute respiratory syndrome treated with oseltamivir: a 12-year longitudinal study. Int J Clin Exp Med. 2019;12(10):12464-71.) |
2019 |
China |
Prospective |
SARS |
144 |
67 |
Oseltamivir |
29.91±10.11 |
32 |
24.03±8.40 |
Back to work Quality of life |
8 |
|
|
|
|
|
|
|
Placebo |
36.97±13.24 |
48 |
16.26±7.24 |
|
|
Li et al.(2626. Li TS, Gomersall CD, Joynt GM, Chan DP, Leung P, Hui DS. Long-term outcome of acute respiratory distress syndrome caused by severe acute respiratory syndrome (SARS): an observational study. Crit Care Resusc. 2006;8(4):302-8.) |
2006 |
Hong Kong |
Retrospective |
SARS |
3, 6 and 12 |
59 |
- |
47±15.7 |
58 |
9 (5–20) |
Mortality Quality of life Functional capacity Pulmonary function |
9 |
Ngai et al.(2727. Ngai JC, Ko FW, Ng SS, To KW, Tong M, Hui DS. The long-term impact of severe acute respiratory syndrome on pulmonary function, exercise capacity and health status. Respirology. 2010;15(3):543-50.) |
2010 |
Hong Kong |
Prospective |
SARS |
3, 6, 12, 18 and 24 |
123 |
- |
33.4±8.6 |
41.8 |
- |
Back to work Quality of life Functional capacity Pulmonary function |
9 |
Yin et al.(2828. Yin CH, Wang C, Wen Y, Jiang L, Liu Y, Jiao YM, et al. Clinical study on high-resolution CT and pulmonary function in severe acute respiratory syndrome patients during recovery phase. Chin Med J (Engl). 2005;118(6):512-5.) |
2005 |
China |
Prospective |
SARS |
1, 3 and 6 |
93 |
- |
39.8±13.8 |
31.9 |
- |
Pulmonary function |
5 |
Hui et al.(2929. Hui DS, Joynt GM, Wong KT, Gomersall CD, Li TS, Antonio G, et al. Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors. Thorax. 2005;60(5):401-9.) |
2005 |
Hong Kong |
Prospective |
SARS |
1, 3 and 6 |
110 |
- |
35.6±9.8 |
40 |
13.5±15.6 |
Quality of life Functional capacity Pulmonary function |
8 |
Skinner et al.(3030. Skinner EH, Haines KJ, Howe B, Hodgson CL, Denehy L, McArthur CJ, et al. Health-related quality of life in australasian survivors of H1N1 influenza undergoing mechanical ventilation a multicenter cohort study. Ann Am Thorac Soc. 2015;12(6):895-903.) |
2015 |
Australia |
Prospective |
H1N1 |
12 |
62 |
- |
42 (29–53) |
48 |
20.0 (15–38) |
Quality of life |
7 |